The Latest Cardiac and Vascular News
WESTMINSTER, Colo., April 18, 2022 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that its Board of Directors has established a Special Committee to evaluate strategic options for maximizing stockholder value. The Company believes […]
MONTREAL and CHARLOTTE, N.C., April 15, 2022 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Milestone’s Compensation Committee granted one new employee 65,000 incentive stock options at a per share exercise price of $6.85, the closing price of Milestone’s common stock on April […]
AUDUBON, Pa.–(BUSINESS WIRE)–AIROS® Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy products that treat lymphedema and venous disorders, today announced it has hired Adrien Grey MacKenzie, LMT, PTA, CLT-LANA and Kelly Sturm, DPT, CLT-LANA as clinical advisors. Ms. MacKenzie is a national board-certified health and wellness […]
MONMOUTH JUNCTION, N.J., April 14, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that it has registered a new subsidiary, CytoSorbents Medical UK Limited, with plans to establish a direct sales presence within the United Kingdom (UK) and Ireland. CytoSorbents previously sold […]
WASHINGTON, April 13, 2022 /PRNewswire/ — Anekwe E. Onwuanyi, MD, FACC, was installed as the 19th President of the Association of Black Cardiologists (ABC) during the Spring 2022 Membership Meeting. He is the first board-certified, advanced heart failure specialist to hold the position in ABC’s nearly 50-year history. Dr. Onwuanyi is Professor of Medicine […]
WALTHAM, Mass., April 12, 2022 /PRNewswire/ — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that on April 5, 2022, the compensation committee of the company’s board of directors granted five new non-executive employees options […]
VANCOUVER, April 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) is pleased to announce the results of the votes on matters considered at its Annual General and Special Meeting of Shareholders held on April 12, 2022 in Vancouver, B.C. (the “Meeting”). At the Meeting, the […]
MORRISVILLE, N.C., April 12, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (“Liquidia”) announced today that it has commenced an underwritten public offering of its common stock. All of the shares in the proposed offering will be sold by Liquidia. In addition, Liquidia expects to grant the underwriters a 30-day […]
77K square-foot facility to accommodate growth NEWTON, Mass.–(BUSINESS WIRE)–Corindus, A Siemens Healthineers Company and a leading developer of precision vascular robotics, announced today the opening of its new headquarters at 275 Grove Street in Newton, Mass. Siemens Healthineers relocated the Corindus headquarters from its previous location in Waltham to accommodate […]
The state-of-the-art cGMP facility, located in Sarasota, will help further solidify Florida as a global leader in biosciences SARASOTA, Fla.–(BUSINESS WIRE)–Akron Bio, a leading developer and manufacturer of critical building blocks used by biopharma to produce advanced therapies for the prevention and treatment of cardiovascular diseases and cancers, today launched […]
